The use of telaprevir for the treatment of hepatitis C in patients undergoing liver transplantation (Literature review and clinical experience)
Authors reviewed published data concerning antiviral treatment of liver transplant recipients with 1st generation HCV protease inhibitors (telaprevir and boceprevir). Efficacy and adverse events have been analyzed with peculiar attention to drug-drug interactions between calcineurin inhibitors and H...
Main Authors: | M. Sh. Khubutiya, V. E. Syutkin, N. I. Geyvandova, A. A. Salienko, T. V. Gudzovskaya, M. S. Novruzbekov |
---|---|
Format: | Article |
Language: | English |
Published: |
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
2016-02-01
|
Series: | Трансплантология (Москва) |
Subjects: | |
Online Access: | https://www.jtransplantologiya.ru/jour/article/view/34 |
Similar Items
-
Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C
by: Xavier Forns, et al.
Published: (2016-07-01) -
Telaprevir in treatment of chronic hepatitis C: safety issues
by: T. M. Ignatova
Published: (2012-07-01) -
Cutaneous Eruption due to Telaprevir
by: Eduardo Mastrangelo Marinho Falcão, et al.
Published: (2015-09-01) -
Haemophagocytic syndrome in a liver transplant patient during treatment with Telaprevir
by: Beatriz Rodríguez-Medina, et al.
Published: (2013-11-01) -
Telaprevir: New possibilities for antiviral treatment in patients with chronic hepatitis C
by: I G Nikitin, et al.
Published: (2012-11-01)